Skip to main content
Open Access Publications from the University of California

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial

  • Author(s): Bastian, Boris
  • Behr, Spencer
  • McCalmont, Timothy
  • Algazi, AP
  • Cha, E
  • Ortiz-Urda, SM
  • McCalmont, TH
  • Bastian, BC
  • Hwang, J
  • Pampaloni, MH
  • Chong, K
  • Cortez, B
  • et al.

Published Web Location
No data is associated with this publication.

© Cancer Research UK Background:Simultaneous chemotherapy with vascular endothelial growth factor (VEGF) inhibition has not shown additional benefit over chemotherapy alone in advanced melanoma. We tested administration of the potent VEGF inhibitor axitini

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item